PCS Biosecurity aspires to become the leader in indoor sanitization by offering patented, innovative solutions that will revolutionize sanitization processes globally.
PCS Biosecurity products effectively and safely clean indoor surfaces and air. By continuously deploying plasmaclusters, these innovative solutions actively combat pathogens, particulate matter, and volatile organic compounds, ensuring the safety of occupants.
Below is a brief list of viruses, bacteria, and molds that can be mitigated or eliminated by plasmacluster technology.
Plasmacluster technology decreases airborne particulate matter through a process called agglomeration. Introducing plasmacluster concentrations to the air results in the agglomeration of airborne submicron particles, making them more easily filtered or heavy enough to fall out of suspension.
Plasmacluster technology also breaks down harmful Volatile Organic Compounds (VOCs) into harmless compounds such as O2, CO2, N2, and H2O.
Plasmaclustering technology is remarkably effective in inhibiting airborne dust mites and fungal allergens, both major causes of indoor allergies. The technology also inactivates indoor cat allergens by preventing allergens binding capacity.
Plasmaclustering technology is effective at combating odors resulting from airborne bacteria and ammonia, fatty acids & polysaccharides.
After one hour of exposure to PCS Biosecurity technology, skin has 6% more moisture content as compared to a control. This skin moisture preservation under a plasmacluster field is the result of a mechanism in which water molecules of the charged particles form a water molecule coating on the surface of the skin.
Independent studies have shown that plasmacluster technology is exceptionally effective in preventing seasonal depression, surpassing the effectiveness of even anti-depressant drugs.
PCS Biosecurity measures target environment anion density to estimate technology efficacy. However, PCS Biosecurity technology is utilized in numerous applications with a wide variety of target environment conditions. Target environment conditions should be evaluated when determining the efficacy of PCS Biosecurity technology. The use of PCS Biosecurity technology is not intended to replace existing disease transmission prevention measures. Applicable federal, state, and local health guidelines, including guidelines published by the Center for Disease Control and Prevention, should be followed. PCS Biosecurity products have not been evaluated by the FDA as medical devices and are not intended to prevent, treat, or cure infections or diseases caused by certain viruses or bacteria. The use of this technology is not intended to take the place of reasonable precautions to prevent the transmission of disease along with your business's best practices, if applicable.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.